Generics and biosimilars

Statistics report about generic drugs and biosimilars

Generics and biosimilars

This report presents graphs and tables about the global generic drug industry and market. It also includes a chapter about biosimilars, complex, almost identical copies of biological drugs, which like generic drugs, have the potential for significant drug spending reductions.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Global overview

4
  • Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
  • Basic Statistic Worldwide generic prescription drug sales 2012-2026
  • Basic Statistic Global generic prescription drug revenues as share of prescribed revenue 2012-2026
  • Premium Statistic Patent expiration risk for total worldwide global Rx drug revenue 2024-2030

Top companies

4
  • Premium Statistic Revenues of leading global generics manufacturers 2022
  • Premium Statistic Teva Pharmaceutical Industries' generic revenues by region 2016-2023
  • Premium Statistic Novartis revenue 2014-2023 by segment
  • Basic Statistic Pfizer's revenue by segment 2017-2019

U.S. market

6
  • Premium Statistic Brand and generic prescription medication spending in the U.S. 2006-2021
  • Premium Statistic U.S. brand and generic prescription drug spending 2017-2021
  • Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
  • Premium Statistic Unbranded generics revenue top corporations in U.S. 2017-2018
  • Premium Statistic Unbranded generics market share top corporations in U.S. 2017-2018
  • Premium Statistic Top pharma products by prescriptions U.S. 2022

Patent expiration

6
  • Premium Statistic Projected sales at risk due to patent expiry 2014-2023
  • Premium Statistic Top pharma companies by sales loss due to patent loss until 2018
  • Premium Statistic Forecast of new brand and LOE impact in developed pharma markets 2019-2026
  • Premium Statistic Top branded biologic drugs in the U.S. that will go generic by 2028
  • Premium Statistic Time from brand drug launch to generic patent challenges U.S. 1995-2014
  • Basic Statistic Comparison of pre-expiry and generic price for drugs U.S. 2015

Savings

7
  • Premium Statistic Savings through generic drug usage in the U.S. 2008-2023
  • Premium Statistic Total savings of top generic drugs in U.S. 2023
  • Premium Statistic Saving of U.S. costs through generic pharmaceuticals by condition 2023
  • Basic Statistic Savings through generic drug usage in the U.S., by age group 2023
  • Basic Statistic Savings through generic drug usage in the U.S., by payer 2023
  • Basic Statistic Percentage savings through generic drug usage in the U.S. by payer 2023
  • Basic Statistic Savings through generic drug usage in the U.S., by age group share 2023

Biosimilars

7
  • Premium Statistic Cumulative potential biosimilars market in EU5 countries and the U.S. 2016-2020
  • Premium Statistic Country-wise biosimilar pipelines number in development worldwide 2017
  • Premium Statistic Reduction in U.S. direct spending on originator biologics as of 2018
  • Premium Statistic Share of filgrastim sales attributable to Neupogen or biosimilars US 2015-2018
  • Premium Statistic Share of insuline glargine sales Lantus vs. biosimilar US 2015-2017
  • Premium Statistic Opinion on drug spending reduction due to biosimilars for specialty drugs 2017-2020
  • Basic Statistic Physician office payment for biosimilars in Medicare Part B 2022
Report this content
FURTHER REPORTS

Recommended and recent reports

  • Healthcare in the Philippines
  • Children's health in the U.S.
  • Cancer in the U.S.
  • Digital health
  • Medical technology industry
  • Physicians in the U.S.
  • Diabetes
  • Sleep in the U.S.
  • CVS Health
  • Cardiovascular disease in the U.S.
  • Generics and biosimilars in Italy
  • Health in Thailand
  • Pharmaceutical market in Italy
  • Diabetes in the U.S.
  • Pregnancy in the United States
  • Abbott Laboratories
  • Long-term care in the U.S.
  • HIV/AIDS in Africa
  • Medtronic
  • Global health care systems comparison

Recommended statistics

You may also be interested in...

Statista report shop

Explore all Statista reports

We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.

Statista report shop Go to reports

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)
Email
support@statista.com

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)
Email
asia.support@statista.com

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)
Email
eu.support@statista.com

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Email
latam@statista.com

Mon - Fri, 9am - 6pm (EST)